# ENB Financial Corp: overview ENBP · OTC · CIK 1437479 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/enbp.md) · [Financials](/companies/enbp/financials.md) · [Filings](/companies/enbp/filings.md) · [Insiders](/companies/enbp/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | [0.76](/filings/0001174947-26-000608.md) | [1.02](/filings/0001174947-26-000805.md) | not reported | not reported | [0.71](/filings/0001174947-26-000608.md) | [1.00](/filings/0001174947-26-000805.md) | | Free cash flow | $k | [2,946 d](/filings/0001174947-25-001388.md) | [2,765 d](/filings/0001174947-26-000410.md) | [3,121](/filings/0001174947-26-000608.md) | [4,753 d](/filings/0001174947-26-000805.md) | [7,902 d](/filings/0001174947-25-001388.md) | [3,399 d](/filings/0001174947-26-000410.md) | [2,792](/filings/0001174947-26-000608.md) | [5,568 d](/filings/0001174947-26-000805.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [2.62](/filings/0001174947-24-000388.md) | [2.19](/filings/0001174947-25-000372.md) | [2.71](/filings/0001174947-26-000410.md) | [3.80](/filings/0001174947-26-000410.md) | | Free cash flow | $m | [12.2](/filings/0001174947-23-000382.md) | [19.4](/filings/0001174947-24-000388.md) | [28.6](/filings/0001174947-25-000372.md) | [11.5](/filings/0001174947-26-000410.md) | [19.2](/filings/0001174947-26-000410.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/enbp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [KERR FINANCIAL PLANNING Corp](/funds/2095947.md) | 2026-06-30 | $141.3k | 5,000 | | Unchanged | | [Comprehensive Financial Planning, Inc./PA](/funds/2044855.md) | 2026-06-30 | $51.7k | 1,878 | | Unchanged | ## Recent filings [All 759 filings](/companies/enbp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 19:12 ET | [8-K](/filings/0001174947-26-000931.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-26-000931 | | 2026-10-22 | 15:43 ET | [8-K](/filings/0001174947-26-000927.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-26-000927 | | 2026-09-21 | 16:10 ET | [8-K](/filings/0001174947-26-000884.md) | 5.02 Departure or appointment of officers or directors | 0001174947-26-000884 | | 2026-08-14 | 16:59 ET | [10-Q](/filings/0001174947-26-000805.md) | Quarterly report, period 2026-06-30 | 0001174947-26-000805 | | 2026-07-27 | 13:22 ET | [8-K](/filings/0001174947-26-000705.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-26-000705 | | 2026-07-16 | 16:05 ET | [8-K](/filings/0001174947-26-000687.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-26-000687 | | 2026-05-15 | 20:05 ET | [10-Q](/filings/0001174947-26-000608.md) | Quarterly report, period 2026-03-31 | 0001174947-26-000608 | | 2026-05-06 | 14:46 ET | [8-K](/filings/0001174947-26-000551.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001174947-26-000551 | | 2026-04-27 | 13:05 ET | [8-K](/filings/0001174947-26-000514.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-26-000514 | | 2026-04-17 | 13:35 ET | [8-K/A](/filings/0001174947-26-000488.md) | 9.01 Financial statements and exhibits | 0001174947-26-000488 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001174947-26-000410.md), filed Mar 20, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1437479 - Tickers: ENBP - Exchange: OTC - SIC code: 6021 National Commercial Banks - State of incorporation: PA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.